Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast

C Weston1, D Poyner, V Patel

  • 1Division of Biomedical Cell Biology, Warwick Medical School, University of Warwick, Coventry, UK.

Abstract

Insights

A novel yeast assay reveals distinct G protein signaling preferences for GLP-1 receptor drugs, aiding the development of safer type 2 diabetes treatments.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • The glucagon-like peptide 1 (GLP-1) receptor is crucial for glycemic control and a key target for type 2 diabetes therapies.
  • Adverse effects of current GLP-1 receptor agonists suggest a need for deeper understanding of their signaling pathways.

Purpose of the Study:

  • To develop a novel yeast-based assay for studying GLP-1 receptor G protein coupling selectivity.
  • To investigate signaling bias of GLP-1 receptor ligands and allosteric modulators.

Main Methods:

  • Expression of the GLP-1 receptor in modified yeast strains coupled to G protein chimeras.
  • Assessing receptor activation and G protein coupling preferences via cell growth.
  • Quantifying ligand-receptor interactions and G protein selectivity.

Main Results:

  • The GLP-1 receptor functionally coupled to human Gαs, Gαi, and Gαq chimeras.
  • Identified distinct G protein signaling bias for liraglutide and exenatide, with exenatide favoring the Gαi pathway.
  • Validated the system for evaluating allosteric compounds and the glucagon receptor.

Conclusions:

  • The yeast platform provides a robust tool for dissecting GLP-1 receptor pleiotropic signaling.
  • Enables screening for more selective and efficacious GLP-1 receptor agonists and modulators.
  • Facilitates the development of improved therapeutics for type 2 diabetes with reduced side effects.

Related Concept Videos

Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
15.7K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.1K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
91.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K